SEC Filings

10-Q
ENVISION HEALTHCARE CORP filed this Form 10-Q on 11/03/2017
Entire Document
 
Item 1. Financial Statements - (continued)

Condensed Consolidating Statement of Cash Flows - For the Nine Months Ended September 30, 2017 (In millions)
 
Parent Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Total Consolidated
Cash flows from operating activities:
 

 
 
 
 
 
 
 
 
Net cash flows provided by (used in) operating activities
$
(16.7
)
 
$
417.7

 
$
485.0

 
$
(325.0
)
 
$
561.0

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
Acquisitions and related expenses
(352.5
)
 
(695.1
)
 

 
353.2

 
(694.4
)
Acquisition of property and equipment
(2.1
)
 
(105.6
)
 
(30.8
)
 

 
(138.5
)
Purchases of marketable securities

 

 
(18.7
)
 

 
(18.7
)
Maturities of marketable securities

 

 
7.2

 

 
7.2

Other, net

 
(20.5
)
 
16.3

 

 
(4.2
)
Net cash flows used in investing activities
(354.6
)
 
(821.2
)
 
(26.0
)
 
353.2

 
(848.6
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
Proceeds from long-term borrowings
789.0

 

 
12.2

 

 
801.2

Repayment on long-term borrowings
(318.0
)
 
(1.1
)
 
(8.9
)
 

 
(328.0
)
Distributions to owners, including noncontrolling interests

 
(125.1
)
 
(374.2
)
 
325.0

 
(174.3
)
Capital contributions

 
352.5

 

 
(352.5
)
 

Changes in intercompany balances with affiliates, net
5.1

 
173.0

 
(178.1
)
 

 

Other, net
(12.4
)
 
(13.4
)
 
2.9

 
(0.7
)
 
(23.6
)
Net cash flows provided by (used in) financing activities
463.7

 
385.9

 
(546.1
)
 
(28.2
)
 
275.3

Net increase (decrease) in cash and cash equivalents
92.4

 
(17.6
)
 
(87.1
)
 

 
(12.3
)
Cash and cash equivalents, beginning of period
41.6

 
59.7

 
230.3

 

 
331.6

Less cash and cash equivalents of held for sale assets, end of period

 
41.2

 

 

 
41.2

Cash and cash equivalents, end of period
$
134.0

 
$
0.9

 
$
143.2

 
$

 
$
278.1



38